Death and dying - Management of patients with end-stage disease

被引:9
|
作者
Leland, JY
机构
[1] Univ S Florida, Coll Med, James A Haley Vet Hosp, Dept Internal Med,Div Geriatr Med, Tampa, FL 33612 USA
[2] James A Haley Vet Hosp, Dept Internal Med, Div Geriatr Med, Hospice & Community Med, Tampa, FL 33612 USA
关键词
D O I
10.1016/S0749-0690(05)70049-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The culture of nursing homes historically has been rehabilitative. This approach has been enforced by the Omnibus Budget Reconciliation Act (1987) regulations, which focus on "decline" as largely avoidable. With the passage of the Prospective Payment System, nursing homes have become increasingly a site of death. In the same way that no sharp transition exists between living and dying, no sharp transition exists between life-prolonging, disease-specific therapy and palliative therapy. Life-prolonging therapy can lead to symptoms that require palliation, and, in some instances, (e.g., end-stage heart failure) life-prolonging therapy and palliative therapy may be indistinguishable. Palliative care, with the control of symptoms, relief of suffering, and promotion of quality of life, is appropriate to all stages of disease, with an increasing proportion of palliative care relative to curative therapy as the disease progresses. The goals of symptom management and attention to potential sources of suffering in palliative care are components of quality end-of-life care and are discussed.
引用
收藏
页码:875 / +
页数:21
相关论文
共 50 条
  • [1] The cost of dying of end-stage liver disease
    Wong, LL
    McFall, P
    Wong, LMF
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (13) : 1429 - 1432
  • [2] Measuring quality of dying in end-stage renal disease
    Cohen, LM
    Germain, MJ
    SEMINARS IN DIALYSIS, 2004, 17 (05) : 376 - 379
  • [3] Cancer management in patients with end-stage renal disease
    Eneman, Jonathan D.
    Philips, George K.
    ONCOLOGY-NEW YORK, 2005, 19 (09): : 1199 - 1212
  • [4] Management of Elderly Patients With End-Stage Kidney Disease
    Dimkovic, Nada
    Oreopoulos, Dimitrios
    SEMINARS IN NEPHROLOGY, 2009, 29 (06) : 643 - 649
  • [5] Perioperative Management of Patients With End-Stage Renal Disease
    Kanda, Hirotsugu
    Hirasaki, Yuji
    Iida, Takafumi
    Kanao-Kanda, Megumi
    Toyama, Yuki
    Chiba, Takashi
    Kunisawa, Takayuki
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2017, 31 (06) : 2251 - 2267
  • [6] Management of End-stage Liver Disease
    Liou, Iris W.
    MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) : 119 - +
  • [7] End-Stage Renal Disease and Arrhythmic Death
    Weinrauch, Larry A.
    Charytan, David M.
    D'Elia, John A.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2018, 4 (07) : 975 - 976
  • [8] Management of end-stage lung disease
    Galván, AP
    ARCHIVOS DE BRONCONEUMOLOGIA, 2004, 40 (02): : 51 - 53
  • [9] National Trends in Location of Death in Patients With End-Stage Liver Disease
    Kaplan, Alyson
    Fortune, Brett
    Ufere, Nneka
    Brown, Robert S., Jr.
    Rosenblatt, Russell
    LIVER TRANSPLANTATION, 2021, 27 (02) : 165 - 176
  • [10] Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease
    Wong, CS
    Hingorani, S
    Gillen, DL
    Sherrard, DJ
    Watkins, SL
    Brandt, JR
    Ball, A
    Stehman-Breen, CO
    KIDNEY INTERNATIONAL, 2002, 61 (02) : 630 - 637